Genospectra has appointed Ron Hahn to its board, the Fremont, Calif.-based company said last week. Hahn, a venture capitalist focusing on health care and life sciences, is a partner of Battelle Ventures, which led Genospectra’s recent financing round.
Applied Biosystems has named Lars Holmkvist as president of the company’s European region. Holmkvist will manage approximately 1,000 employees in that region, and will report to Catherine Burzik, AB’s president, the company said.
Holmkvist most recently served as vice president of vascular and cardiac surgery in Western Europe for Medtronic. He has also been vice president, vascular for Europe, the Middle East, and Africa for Boston Scientific, and held executive positions with Pharmacia Hospital Care and Becton Dickinson.
Robert Millman has been appointed chief patent counsel of Alnylam Pharmaceuticals, the Cambridge, Mass.-based company said last week. He has been a company consultant since 2003. Most recently, Millman was a freelance intellectual property consultant for biotechnology companies and the interim chief patent counsel at Infinity Pharmaceuticals. Prior to that, he was chief IP counsel at Celera Genomics. Millman holds a JD degree from the Washington College of Law at American University. He also holds an MS in genetics from Washington State University and a BS in biochemistry from the University of California, Riverside.